You are browsing articles on the topic of Heart Failure Archives - CardioExchange
FDA Approves Right Percutaneous Single Access Heart Pump (29 Jan 2015)
Abiomed has announced that it received FDA approval for its Impella RP System, the first percutaneous single access heart pump that provides support to the right side of the heart. The approval, under a Humanitarian Device Exemption (HDE), is based on results of the single-arm Recover Right study, in which 30 patients were enrolled. The…
Low-Quality Discharge Summaries May Have Consequences (15 Jan 2015)
Leora Horwitz discusses her research group’s study of the association between the quality of discharge summaries and risk for readmission for heart failure.
Eiran Gorodeski discusses his research group’s study of cognitive-impairment screening for patients who are hospitalized for heart failure.
European Review Confirms Increased Risk with Ivabradine (24 Nov 2014)
Following a review provoked by troubling findings that emerged from a large clinical trial, the European Medicines Agency (EMA) is making several recommendations intended to lower the risk of heart problems linked to the heart-rate-lowering drug ivabradine. The drug is marketed by Servier in Europe under the brand names of Corlentor and Procoralan and is indicated for…
Encouraging Results for Two New Drugs for Hyperkalemia (21 Nov 2014)
Two new agents under development may help curb and prevent hyperkalemia, the common and serious side effect of drugs that inhibit the renin-angiotensin-aldosterone system (RAAS), which are the cornerstones of the treatment of chronic kidney disease and heart failure. In a phase 3 study, published online in the New England Journal of Medicine, researchers first randomized…
Encouraging Results For Two New Drugs For Hyperkalemia (21 Nov 2014)
Two new agents under development may help curb and prevent hyperkalemia, the common and serious side effect of drugs that inhibit the renin-angiotensin-aldosterone system (RAAS), which are the cornerstones of the treatment of chronic kidney disease and heart failure. … Click here to read the full post on Forbes.
Tariq Ahmad discusses his research group’s study of clinical phenotypes in patients with chronic systolic heart failure.
For two decades, investigators have been studying the association between neighborhood characteristics and cardiovascular disease. A landmark study from 2001 showed that living in a socioeconomically disadvantaged neighborhood was associated with higher incidence of coronary artery disease. Several studies have also shown an association between neighborhood characteristics, most notably the socioeconomic status (SES) and outcomes…
The Implications of PARADIGM-HF for Clinical Practice (29 Sep 2014)
Clyde Yancy and Mary Norine Walsh offer their perspectives on the much-discussed PARADIGM-HF trial.